Axogen (AXGN) FCF Margin (2010 - 2026)
Axogen's quarterly FCF Margin came in at 1.99% in Q1 2026, up 2568.0% year-on-year from 0.07% in Q1 2025, and down 153.31% quarter-over-quarter from 0.79% in Q4 2025.
Axogen has reported FCF Margin for 17 years, with the latest figure at 1.99% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 2568.0% year-over-year to 1.99%; the trailing twelve-month figure through Mar 2026 stood at 3.9% (up 350.0% YoY), and the FY2025 full-year result was 1.3%, down 207.0% from the prior year.
- FCF Margin for Q1 2026 stood at 1.99%, down from 0.79% in the prior quarter.
- The five-year high for FCF Margin was 16.32% in Q4 2024, with the low at 51.89% in Q1 2022.
- Average FCF Margin over 5 years is 10.05%, with a median of 1.99% recorded in 2026.
- Year-over-year, FCF Margin plunged 4281 bps in 2022 and surged 4715 bps in 2024.
- Tracing AXGN's FCF Margin over 5 years: stood at 14.54% in 2022, then tumbled by 112 bps to 30.82% in 2023, then soared by 153 bps to 16.32% in 2024, then tumbled by 105 bps to 0.79% in 2025, then sank by 153 bps to 1.99% in 2026.
- The last three FCF Margin figures came in at 1.99% (Q1 2026), 0.79% (Q4 2025), and 5.19% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | -1.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.99% |
| Dec 31, 2025 | -0.79% |
| Sep 30, 2025 | 5.19% |
| Jun 30, 2025 | 13.86% |
| Mar 31, 2025 | -27.67% |
| Dec 31, 2024 | 16.32% |
| Sep 30, 2024 | 3.39% |
| Jun 30, 2024 | 9.40% |
| Mar 31, 2024 | -30.89% |
| Dec 31, 2023 | -30.82% |
| Sep 30, 2023 | 6.28% |
| Jun 30, 2023 | 7.28% |
| Mar 31, 2023 | -31.99% |
| Dec 31, 2022 | -14.54% |
| Sep 30, 2022 | -13.69% |
| Jun 30, 2022 | -28.26% |
| Mar 31, 2022 | -51.89% |
| Dec 31, 2021 | -4.67% |
| Sep 30, 2021 | 29.12% |
| Jun 30, 2021 | -25.38% |
| Mar 31, 2021 | -44.83% |
| Dec 31, 2020 | -54.77% |
| Sep 30, 2020 | 43.47% |
| Jun 30, 2020 | -74.78% |
| Mar 31, 2020 | -48.33% |
| Dec 31, 2019 | -15.33% |
| Sep 30, 2019 | -17.41% |
| Jun 30, 2019 | -22.10% |
| Mar 31, 2019 | -40.13% |
| Dec 31, 2018 | -22.22% |
| Sep 30, 2018 | -36.91% |
| Jun 30, 2018 | -21.23% |
| Mar 31, 2018 | -35.94% |
| Dec 31, 2017 | -9.06% |
| Sep 30, 2017 | -15.03% |
| Jun 30, 2017 | -15.44% |
| Mar 31, 2017 | -33.11% |
| Dec 31, 2016 | -7.66% |
| Sep 30, 2016 | -22.60% |
| Jun 30, 2016 | -27.46% |
| Mar 31, 2016 | -61.79% |
| Dec 31, 2015 | -52.21% |
| Sep 30, 2015 | -36.79% |
| Jun 30, 2015 | -56.46% |
| Mar 31, 2015 | -50.90% |
| Dec 31, 2014 | -54.88% |
| Sep 30, 2014 | -50.50% |
| Jun 30, 2014 | -63.06% |
| Mar 31, 2014 | -106.62% |
| Dec 31, 2013 | -83.61% |
| Sep 30, 2013 | -98.69% |
| Jun 30, 2013 | -88.46% |
| Mar 31, 2013 | -124.93% |
| Dec 31, 2012 | -165.52% |
| Sep 30, 2012 | -92.40% |
| Jun 30, 2012 | -49.08% |
| Mar 31, 2012 | -151.66% |
| Dec 31, 2011 | -161.66% |
| Sep 30, 2011 | -212.87% |
| Jun 30, 2011 | -106.53% |
| Mar 31, 2011 | -103.16% |
| Dec 31, 2010 | -87.42% |
| Sep 30, 2010 | -171.46% |